Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia
- Conditions
- Heparin-Induced ThrombocytopeniaThrombosisBiomarkers
- Interventions
- Diagnostic Test: HIT with thrombosis
- Registration Number
- NCT03269019
- Lead Sponsor
- Wuhan Asia Heart Hospital
- Brief Summary
Heparin induced thrombocytopenia (HIT) is a kind of catastrophic thrombotic complications after the application of heparin. If HIT without treatment, death rate is as high as 30% to 50%. Early diagnosis of HIT and prevention of thrombosis is very important.
This study is planned to assess the use of thrombotic biomarkers in patients with HIT, including thrombin-antithrombin complex, d-dimer, fibrin degradation products and Thrombelastograghy monitoring . These biomarkers are monitored in 5-14 days post-operation to assess the risk of thrombosis in HIT patients. All patients were followed up for 30 days, and clinical outcomes, including new thrombus and death, were recorded during follow-up.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 200
- Hospitalized patients undergoing cardiac surgery.
- Receiving unfractionated heparin anticoagulation.
- history of heparin-induced thrombocytopenia
- pregnant woman
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description HIT-group HIT with thrombosis The patients with heparin-induced thrombocytopenia. HITTs-group HIT with thrombosis The patients with heparin-induced thrombocytopenia with thrombosis.
- Primary Outcome Measures
Name Time Method Deaths 30 days All-cause deaths
Thrombotic event 30 days New thrombosis, including deep venous thrombosis,pulmonary embolism,Cerebral infarction,superior mesenteric artery embolism,artery embolism etc.
- Secondary Outcome Measures
Name Time Method